428 results on '"Palmieri, Fabrizio"'
Search Results
2. Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease
3. The role of integrated psychological support in breast cancer patients: a randomized monocentric prospective study evaluating the Fil-Rouge Integrated Psycho-Oncological Support (FRIPOS) program
4. Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
5. Update of drug-resistant tuberculosis treatment guidelines: A turning point
6. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
7. Epidemiology of ventilator-associated pneumonia in ICU COVID-19 patients: an alarming high rate of multidrug-resistant bacteria
8. Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
9. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
10. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
11. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
12. Implementation of Whole Genome Sequencing of Tuberculosis Isolates in a Referral Center in Rome: Six Years’ Experience in Characterizing Drug-Resistant TB and Disease Transmission
13. Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective Study
14. Diagnosis of Tuberculosis in a Case of Chronic Urticaria following Omalizumab Therapy
15. Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases
16. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
17. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
18. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020
19. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
20. Challenges and Pitfalls of PEA Calibration with Fast Charge Accumulating Materials
21. A randomized trial of pamrevlumab in patients with COVID‐19 pneumonia
22. Tuberculin skin test – Outdated or still useful for Latent TB infection screening?
23. First description of agonist and antagonist IP-10 in urine of patients with active TB
24. Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes
25. Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: a case report
26. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection
27. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
28. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
29. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
30. Characterization of the immune impairment of tuberculosis and COVID-19 coinfected patients
31. The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications
32. Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
33. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
34. Use of several immunological markers to model the probability of active tuberculosis
35. Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
36. Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection
37. Identification of HLA-E Binding Mycobacterium tuberculosis–Derived Epitopes through Improved Prediction Models
38. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
39. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
40. Antibiotics and Infectious Respiratory Diseases
41. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study
42. Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
43. Timing and outcomes of noninvasive ventilation in 307 ARDS COVID-19 patients: an observational study in an Italian third level COVID-19 hospital
44. Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients
45. Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
46. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study
47. Additional file 1 of Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
48. Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)
49. Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review
50. B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.